BACKGROUND Learning disability and short stature are cardinal signs of Down’s syndrome. Insulin-like growth factor I (IGF-I), regulated by growth hormone (GH) from about 6 months of age, may be ...
Objective We systematically evaluated health and nutrition programmes to identify context-specific interventional packages that might help to prioritise the implementation of programmes for reducing ...
Correspondence to Dr Yasheer Venay Haripersad, Perth Children's Hospital, Nedlands, WA 6909, Australia; Yasheer.Haripersad{at}health.wa.gov.au Perth Children’s Hospital is the sole tertiary paediatric ...
In this issue’s Voices from literature article, the authors, Borgia and Calandrino, comment on Luigi Pirandello’s (1867–1936) ...
Background National and international guidelines recommend that psychosocial support should be a key component of the care offered to children and adolescents experiencing gender ...
Correspondence to Dr Andrew Mumford Bristol Heart Institute, University of Bristol, Level 7 Bristol Royal Infirmary, Bristol BS2 8HW, UK; a.mumford{at}bristol.ac.uk Purpura fulminans (PF) is a ...
Correspondence to Dr Evelien Snauwaert, Department Paediatric Nephrology (3K12D), Ghent University Hospital, De Pintelaan 185, Ghent 9000, Belgium; evelien.snauwaert{at}uzgent.be Purpose Since 1997, ...
3 The Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK Correspondence to Dr Sandeep Jayawant, Department of Paediatrics, University of Oxford, ...
GP122 Is treatment with atropine 0.01% eyedrops safe to prevent the progression of childhood myopia?
Introduction In 2016 the effectiveness of atropine eyedrops in preventing the progression of myopia in children was confirmed. Atropine produces parasympathetic inhibition because avoids the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results